About ViaNautis
ViaNautis is transforming cell and gene therapy with polyNaut®, a versatile, non-viral, targeted polymer-based nanovesicles delivery system that enables precise
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Cambridge, United Kingdom
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
vianautis.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@ViaNautisBio
(45 followers)
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised undisclosed · Series-A
fundraisingfox.com
- Capital Raise
Raised $25,000,000 · Series-A
startupintros.com
Investors & Backers
4BIO Capital
Abcam
BGF Ventures
Cystic Fibrosis Foundation
Eli Lilly
Meltwind Advisory
O2h Ventures
Origin Capital
SCI Ventures
UCB Ventures
Funding History
Series-A equity
· Oct 31, 2024
undisclosed fundraisingfox.com
Series-A equity
· Nov 13, 2023
$25,000,000 startupintros.com
Founders & Leadership
Adi Hoess
CEO
Work email & phone locked
Unlock →
Denis Cecchin
Founder
Work email & phone locked
Unlock →
Francesca Crawford
Founder
Work email & phone locked
Unlock →
Giuseppe Battaglia
Founder
Work email & phone locked
Unlock →
Ray Jupp
Chief Scientific Officer
Work email & phone locked
Unlock →
Sam Smart
Chief Financial Officer
Work email & phone locked
Unlock →
Samuel Barker
Chief Business Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026